WE HELP YOU KEEP YOUR FEET

    VOTIS. A revolutionary new tool to safely screen, stage, and monitor the diabetic foot.

    WE HELP YOU KEEP YOUR FEET

    VOTIS is seeking investigators to lead clinical trials of our medical device for PAD diagnosis.

    Would you like to participate as an investigator in our clinical trials?

    VOTIS is a revolutionary new tool to safely screen, stage, and monitor the diabetic foot.

    Z

    VOTIS provides a clinical decision support for diagnosis and monitoring of diabetic foot syndrome and related conditions.

    Z

    VOTIS is designed for safe and repeated use over time, and for acute use during surgical procedures.

    Z

    VOTIS provides objective, repeatable, and measurable data useful to the doctor — regardless of treatment options being used.

    Z

    VOTIS is non-invasive and ionizing-radiation-free.

    This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 876589.
    Diabetic foot

    Need

    Chronic limb-threatening ischemia (CLTI) is an end-stage condition of peripheral artery disease (PAD), which hinders blood flow in the arteries of the leg.

    Z

    PAD affects more than 200 MILLION PEOPLE worldwide.

    Z

    CLTI affects 20 MILLION PEOPLE worldwide, 5 MILLION in the US and Europe.

    Z

    75 THOUSAND non-major amputations (about 2/3 of all amputations) are performed each year in the US.

    Solution

    VOTIS accompanies the PAD/CLTI patient throughout the patient journey.

    PedCheckT

    The patient’s feet are screened for Peripheral Artery Disease.

    Most likely, the patient is diabetic and 50 years old or older, or is younger but has had active diabetes for 10 years, or is younger and smokes.

    PedStageTM

    The patient’s specialists assess blood flow, oxygen flow in the foot, severity of ulcers or gangrene, and infection.

    The health of the patient’s foot is assessed regularly for clinical decision support as various treatment options are applied.

    PedFloTM

    The doctor performing revascularization, bypass, open surgery, or minor or partial amputation uses the PedFlo™ to assess blood flow in the foot in real time.

    For the first time, doctors can properly see what they are doing:

    P e d S t a g e ™ shows precise location and severity of disease.

    An angiosome is an anatomical unit of tissue fed by a source artery and drained by specific veins.

    The foot is divided into multiple angiosomes.

    By identifying which areas of the foot lack perfusion, the doctor can identify occluded arteries in the leg.

    P e d F l o ™ highlights significant changes to blood flow in real time.

    Pedflo
    Sudden change in hemoglobin in foot at injection of contrast dye into femoral artery at groin.

    Portable, inexpensive, easy-to-use

    Z

    Votis is an inexpensive portable device

    Z

    Single-use consumable patches affixed to foot encase reusable laser diodes and photodetector sensors that automatically measure scattering and absorption of the light.

    Z
    Patches connect to small, lightweight unit that transmits information digitally via the cloud.
    Z

    Data is automatically converted into 3-digit (0-3) Wound, Ischemia, Foot-Infection (WIFI) Scale score.

    Votis machine

    To watch the video describing the procedure please contact us

    If you have the code

    Technology

    Solid IP position

    Protects VOTIS technology and creates competitive barrier to entry.

    Z

    Seven issued US patents licensed from Columbia University cover hardware, software and cloud-based AI.

    Z

    License includes proprietary devices and processes developed in the lab and in the field during studies of human subjects.

    Viable development plan to bring screening, staging, and intraoperative devices to market.

    Team

    Merrill Weber, JD

    Merrill Weber, JD

    Co-Founder, CEO & President

    Previously, president of vascular medical device company sold for >$100 million.

    Andreas H. Hielscher, PhD

    Andreas H. Hielscher, PhD

    Co-Founder & Chief Technology Advisor

    Professor of Biophotonics, Columbia University.
    Device inventor.

    Prof. Brian Glenville, MD

    Prof. Brian Glenville, MD

    Executive Chairman

    Cardiothoracic surgeon, Jerusalem and London, advisor to start-ups and investors.

    Ze'ev Bomzon, PhD

    Ze'ev Bomzon, PhD

    Chief Operating Officer

    Experienced physicist, researcher, and manager in large and small Israeli high-tech companies.

    Bezalel Jacobowitz

    Bezalel Jacobowitz

    Chief Financial Officer

    Accountant with more than 30 years of international operational and business development experience.

    Karin De Hiep

    Karin De Hiep

    Marketing Director

    Former Director, Business Development, Philips New Wellness Solutions, Former Global Marketing Head Geriatrics, GI, Diabetes, Devices, Novartis/Nestle Medical Nutrition

    Hamutal Shahar, PhD

    Hamutal Shahar, PhD

    Director of Clinical Affairs

    Experienced with scientific and operational management of worldwide clinical trials. Extensive background in medical device, medical technology and drug studies.
    Ephraim Siegel

    Ephraim Siegel

    MS Software Architect

    Software designer and developer with 40 years’ experience.

    Steve Epstein

    Steve Epstein

    MSEE

    Cisco Systems Expert in Cloud computing, AI and Large Data Transfer Architecture.

    David G. Armstrong

    David G. Armstrong

    DPM, MD, PhD

    Leading global expert in amputation prevention and diabetic foot. Professor, USC.

    Danielle Bajakian

    Danielle Bajakian

    MD, FACC

    Surgical medical advisor; vascular surgeon and Director, Critical Limb Ischemia Program at Columbia University.

    Roberto Ferraresi, MD

    Roberto Ferraresi, MD

    Interventional cardiologist

    Pioneer in lower limb interventions, particularly in patients with Critical Limb Ischemia, and a worldwide expert in diabetic foot revascularization. Performs more than 600 lower limb interventions per year.

    Tomas Serena

    Tomas Serena

    Founder and CEO of The Serena Group, which runs wound-care centers throughout the US and internationally. Lead or principal investigator in more than 100 clinical trials. Past President, Association for the Advancement of Wound Care. Member, Council, European Wound Management Association.

    SCIENTIFIC ADVISORY BOARD

     

    DAVID ARMSTRONG

    DANIELLE BAJAKIAN

    ROBERTO FERRARESI

     BRIAN GLENVILLE

    ANDREAS HIELSCHER

     BOARD OF DIRECTORS

     

    BRIAN GLENVILLE (Executive Chairman)

    EDWARD KAPLAN

    JERRY KOKOSHKA (Observer)

    YARON SUISSA

    MERRILL WEBER

    CLAUDIO ZUCCOLOTTO

     

    News

    November 2021

    Interview with CEO Merrill Weber for Diabetes Awareness Month on i24 News

    Watch video
    November 2021

    Finding diabetic foot disease before symptoms show up

    Read More
    June 2021
    VOTIS Subdermal Imaging Technologies Raises US$2.5 Million

    Read More
    December 2020

    VOTIS Subdermal Imaging Technologies and ii Ventures announce plans to develop preventative medicine devices to screen for Peripheral Artery Disease in India.

    Read More
    August 2020

    An article “Diabetic foot ulcer management in a multidisciplinary foot centre: one-year healing, amputation and mortality rate” was published in the Journal of Wound Care.

    Read More
    August 2020

    This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 876589

    Read More
    2013

    An article “Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates” was published in Cardio Vascular Diabetology

    Read More

    Contact